Background: Standardization of herbal formulations remains a major analytical challenge due to the presence of multiple bioactive phytoconstituents with overlapping spectral characteristics. Curcumin and quercetin are widely recognized marker compounds with established therapeutic relevance; however, routine quality control methods for their simultaneous estimation are often limited by cost, complexity, and accessibility.
Methods: UV–Visible spectrophotometric method based on simultaneous equation analysis was developed and validated for the concurrent quantification of curcumin and quercetin in herbal formulations. The method utilized methanol as solvent, with analytical wavelengths selected at 425 nm and 370 nm. Validation was performed in accordance with ICH Q2(R1) guidelines, assessing linearity, accuracy, precision, sensitivity, robustness, and applicability to commercial herbal products.
Results: The method demonstrated excellent linearity with correlation coefficients exceeding 0.999 for both analytes. Accuracy studies yielded recovery values within 98–102%, while precision analysis showed %RSD values below 2%. Low limits of detection and quantification confirmed adequate sensitivity. Assay results of marketed herbal formulations were within acceptable pharmacopeial limits, indicating suitability for routine quality control.
Conclusion: The validated method provided a rapid, economical, and reliable analytical tool for simultaneous standardization of curcumin and quercetin in herbal formulations, supporting improved quality assurance and regulatory compliance.
Keywords: Curcumin; Quercetin; UV–Visible spectrophotometry; Simultaneous equation method; Herbal standardization; Method validation
How to cite this article: Ashok LD, Tiwari P, S S P, Laeeq S, Dwivedi A, Gupta SK, Maity D, Khamkat P, Development And Validation Of A UV–Visible Spectrophotometric Method Using Simultaneous Equation Analysis For Standardization Of Curcumin And Quercetin In Herbal Formulations. Int J Drug Deliv Technol. 2026;16(4s): 93-101; DOI: 10.25258/ijddt.16.93-101